Risk of ovarian cancer associated with BMI varies by menopausal status

Journal of Nutrition

Volumn 136, Issue 11, 2006, Pages 2881-2886

  Beehler, Gregory P ^a   Sekhon, Manveen ^b   Baker, Julie A ^b   Teter, Barbara E ^c   McCann, Susan E ^a   Rodabaugh, Kerry J ^a   Moysich, Kirsten B ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CANCER RISK; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MENOPAUSE; OVARY CANCER;

EID: 33751074969     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/136.11.2881     Document Type: Article

References (53)

1. Centers for Disease Control. Ovarian cancer factsheet [homepage on the Internet]. Atlanta: Centers for Disease Control; 2003 [cited 2006 April 25]; Available from: http://www.cdc.gov/cancer/ovarian/about.htm
2. Cannistra SA. Cancer of the ovary. N Engl J Med. 2004;351:2519-29.
3. La Vecchia C. Epidemiology of ovarian cancer: a summary review. Eur J Cancer Prev. 2001;10:125-9.
4. Vaino H, Bianchini F. Weight control and physical activity. 1st ed. Lyon, France: International Agency for Research on Cancer; 2002.
5. Modesitt SC, van Nagell JR, Jr. The impact of obesity on the incidence and treatment of gynecologic cancers: a review. Obstet Gynecol Surv. 2005;60:683-92.
6. Purdie D, Green A, Bain C, Siskind V, Ward B, Hacker N, Quinn M, Wright G, Russell P, Susil B. Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of Women's Health Study Group. Int J Cancer. 1995;62:678-84.
7. Mink PJ, Folsom AR, Sellers TA, Kushi LH. Physical activity, waist-to-hip ratio, and other risk factors for ovarian cancer: a follow-up study of older women. Epidemiology. 1996;7:38-45.
8. Rodriguez C, Calle EE, Fakhrabadi-Shokoohi D, Jacobs EJ, Thun MJ. Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2002;11:822-8.
9. Lukanova A, Bjor O, Kaaks R, Lenner P, Lindahl B, Hallmans G, Stattin P. Body mass index and cancer: results from the Northern Sweden Health and Disease Cohort. Int J Cancer. 2006;118:458-66.
10. Schouten LJ, Goldbohm RA, van den Brandt PA. Height, weight, weight change, and ovarian cancer risk in the Netherlands cohort study on diet and cancer. Am J Epidemiol. 2003;157:424-33.
11. Hoyo C, Berchuck A, Halabi S, Bentley RC, Moorman P, Calingaert B, Schildkraut JM. Anthropometric measurements and epithelial ovarian cancer risk in African-American and White women. Cancer Causes Control. 2005;16:955-63.
12. Riman T, Dickman PW, Nilsson S, Nordlinder H, Magnusson CM, Persson IR. Some life-style factors and the risk of invasive epithelial ovarian cancer in Swedish women. Eur J Epidemiol. 2004;19:1011-9.
13. Purdie DM, Bain CJ, Webb PM, Whiteman DC, Pirozzo S, Green AC. Body size and ovarian cancer: case-control study and systematic review (Australia). Cancer Causes Control. 2001;12:855-63.
14. Mori M, Nishida T, Sugiyama T, Komai K, Yakushiji M, Fukuda K, Tanaka T, Yokoyama M, Sugimori H. Anthropometric and other risk factors for ovarian cancer in a case-control study. Jpn J Cancer Res. 1998;89:246-53.
15. Farrow DC, Weiss NS, Lyon JL, Daling JR. Association of obesity and ovarian cancer in a case-control study. Am J Epidemiol. 1989;129:1300-4.
16. Tornberg SA, Carstensen JM. Relationship between Quetelet's index and cancer of breast and female genital tract in 47,000 women followed for 25 years. Br J Cancer. 1994;69:358-61.
17. Anderson JP, Ross JA, Folsom AR. Anthropometric variables, physical activity, and incidence of ovarian cancer: The Iowa Women's Health Study. Cancer. 2004;100:1515-21.
18. Jonsson F, Wolk A, Pedersen NL, Lichtenstein P, Terry P, Ahlbom A, Feychting M. Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish Twin Registry. [see comment] Int J Cancer. 2003;106:594-9.
19. Fairfield KM, Willett WC, Rosner BA, Manson JE, Speizer FE, Hankinson SE. Obesity, weight gain, and ovarian cancer. Obstet Gynecol. 2002;100:288-96.
20. Dal Maso L, Franceschi S, Negri E, Conti E, Montella M, Vaccarella S, Canzonieri V, Parazzini F, La Vecchia C. Body size indices at different ages and epithelial ovarian cancer risk. Eur J Cancer. 2002;38:1769-74.
21. Peterson N, Trentham-Dietz A, Newcomb P, Chen Z, Gebretsadik T, Hampton J, Stampfer M, Willett W, Egan K. Relation of anthropometric measurements to ovarian cancer risk in a population-based case-control study (United States). Cancer Causes Control. 2006;17:459-67.
22. Zhang M, Xie X, Holman CD. Body weight and body mass index and ovarian cancer risk: a case-control study in China. Gynecol Oncol. 2005;98:228-34.
23. Kuper H, Cramer DW, Titus-Ernstoff L. Risk of ovarian cancer in the United States in relation to anthropometric measures: does the association depend on menopausal status? Cancer Causes Control. 2002;13:455-63.
24. Greggi S, Parazzini F, Paratore MP, Chatenoud L, Legge F, Mancuso S, La Vecchia C. Risk factors for ovarian cancer in central Italy. Gynecol Oncol. 2000;79:50-4.
25. Lukanova A, Toniolo P, Lundin E, Micheli A, Akhmedkhanov A, Muti P, Zeleniuch-Jacquotte A, Biessy C, Lenner P, et al. Body mass index in relation to ovarian cancer: a multi-centre nested case-control study. Int J Cancer. 2002;99:603-8.
26. Engeland A, Tretli S, Bjorge T. Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women. J Natl Cancer Inst. 2003;95:1244-8.
27. Lubin F, Chetrit A, Freedman LS, Alfandary E, Fishler Y, Nitzan H, Zultan A, Modan B. Body mass index at age 18 years and during adult life and ovarian cancer risk. Am J Epidemiol. 2003;157:113-20.
28. Morabia A, Flandre P. Misclassification bias related to definition of menopausal status in case-control studies of breast cancer. Int J Epidemiol. 1992;21:222-8.
29. Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM, Persson IR. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study. Gynecol Oncol. 2001;83:575-85.
30. Holschneider CH, Berek JS. Ovarian cancer: Epidemiology, biology, and prognostic factors. Semin Surg Oncol. 2000;19:3-10.
31. Kurian AW, Balise RR, McGuire V, Whittemore AS. Histologic types of epithelial ovarian cancer: have they different risk factors? Gynecol Oncol. 2005;96:520-30.
32. Fathalla M. Incessant ovulation: a factor in ovarian neoplasia? Lancet. 1971;2:163.
33. Casagrande JT, Louie EW, Pike MC, Roy S, Ross RK, Henderson BE. "Incessant ovulation" and ovarian cancer. Lancet. 1979;2:170-3.
34. Casagrande JT, Pike MC, Henderson BE. Oral contraceptives and ovarian cancer. N Engl J Med. 1983;308:843-4.
35. La Vecchia C. Oral contraceptives and ovarian cancer: an update, 1998-2004. Eur J Cancer Prev. 2006;15:117-24.
36. Ness RB, Cottreau C. Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst. 1999;91:1459-67.
37. Trayhurn P, Wood IS. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans. 2005;33:1078-81.
38. Thorand B, Baumert J, Doring A, Herder C, Kolb H, Rathmann W, Giani G, Koenig W, Group K. Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis. 2006;184:216-24.
39. Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr. 2006;83:S461-5.
40. Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst. 1998;90:1774-86.
41. Lukanova A, Kaaks R. Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiol Biomarkers Prev. 2005;14:98-107.
42. van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, Fraser G, Goldbohm RA, Graham S, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000;152:514-27.
43. Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. [see comment] J Natl Cancer Inst. 1998;90:1774-86.
44. Lukanova A, Lundin E, Zeleniuch-Jacquotte A, Muti P, Mure A, Rinaldi S, Dossus L, Micheli A, Arslan A, et al. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol. 2004;150:161-71.
45. Furstenberger G, Senn HJ. Insulin-like growth factors and cancer. Lancet Oncol. 2002;3:298-302.
46. Lukanova A, Lundin E, Micheli A, Akhmedkhanov A, Rinaldi S, Muti P, Lenner P, Biessy C, Krogh V, et al. Risk of ovarian cancer in relation to prediagnostic levels of C-peptide, insulin-like growth factor binding proteins-1 and -2 (USA, Sweden, Italy). Cancer Causes Control. 2003;14:285-92.
47. Gunnell D, Okasha M, Smith GD, Oliver SE, Sandhu J, Holly JM. Height, leg length, and cancer risk: a systematic review. Epidemiol Rev. 2001;23:313-42.
48. Moysich KB, Mettlin C, Piver MS, Natarajan N, Menezes RJ, Swede H. Regular use of analgesic drugs and ovarian cancer risk. Cancer Epidemiol Biomarkers Prev. 2001;10:903-6.
49. Cornelison TL, Natarajan N, Piver MS, Mettlin CJ. Tubal ligation and the risk of ovarian carcinoma. Cancer Detect Prev. 1997;21:1-6.
50. Suh O, Mettlin C, Petrelli NJ. Aspirin use, cancer, and polyps of the large bowel. Cancer. 1993;72:1171-7.
51. Mettlin C, Croghan I, Natarajan N, Lane W. The association of age and familial risk in a case-control study of breast cancer. Am J Epidemiol. 1990;131:973-83.
52. Mettlin C, Natarajan N, Huben R. Vasectomy and prostate cancer risk. Am J Epidemiol. 1990;132:1056-61.
53. Mettlin C. Milk drinking, other beverage habits, and lung cancer risk. Int J Cancer. 1989;43:608-12.